SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000891092-18-001355
Filing Date
2018-02-14
Accepted
2018-02-14 16:57:11
Documents
2
Group Members
JEREMY MINDICHMATTHEW SIROVICHSCOPIA MANAGEMENT, INC.

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G e77618-13g.htm SC 13G 93110
2 JOINT FILING AGREEMENT e77618ex99-1.htm EX-99.1 4407
  Complete submission text file 0000891092-18-001355.txt   99529
Mailing Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449
Business Address 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080-2449 9082227000
PTC THERAPEUTICS, INC. (Subject) CIK: 0001070081 (see all company filings)

IRS No.: 043416587 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87511 | Film No.: 18613198
SIC: 2834 Pharmaceutical Preparations

Mailing Address 152 WEST 57TH STREET 33RD FLOOR NEW YORK NY 10019
Business Address 152 WEST 57TH STREET 33RD FLOOR NEW YORK NY 10019 212-370-0303
SCOPIA CAPITAL MANAGEMENT LP (Filed by) CIK: 0001279150 (see all company filings)

IRS No.: 300711986 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G